Participants had more energy [.] and became more active Wellness scores improved, with highest effects on mental functioning, improved sleep, increased emotional wellness, and increased energy/vitality. Diastolic blood pressure was reduced. Serum levels of TNF-α were reduced.
The clinical research conducted on ATP 360
® is available on PubMed (PMID: 33882028), originally published in
Alternative Therapies (
Researched Nutritionals
® is committed to backing its formulations with peer-reviewed research. The process of beginning with researched ingredients and then conducting clinical studies is at the heart of our mission, says CEO and founder Dennis Schoen. These scientific studies strengthen the trust of our doctors and their patients because they can quantifiably see the science behind the benefits they re experiencing.
Published: Feb 01, 2021
AngioDynamics Appoints Richard C. Rosenzweig
Senior Vice President, General Counsel and Secretary,
Promotes Juan Carlos Serna to Senior Vice President,
Scientific & Clinical Affairs
LATHAM, N.Y. (BUSINESS WIRE) AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Richard C. Rosenzweig as Senior Vice President, General Counsel, effective January 31, 2021. Mr. Rosenzweig will also serve as Corporate Secretary to the AngioDynamics Board of Directors.
Mr. Rosenzweig succeeds Stephen Trowbridge who has served as Executive Vice President, Chief Financial Officer, and General Counsel since February 2020. Mr. Trowbridge will continue in his role as Executive Vice President and Chief Financial Officer.